PL
BMY icon

Perpetual Ltd’s Bristol-Myers Squibb BMY Stock Holding History

Perpetual Ltd’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Sell
45,645
-17,170
-27% -$986K 0.04% 156
2026
Q1 		$3.81M Sell
62,815
-3,926
-6% -$229K 0.06% 126
2025
Q4 		$3.6M Buy
66,741
+36,562
+121% +$1.76M 0.05% 140
2025
Q3 		$1.36M Buy
30,179
+12,338
+69% +$576K 0.02% 223
2025
Q2 		$826K Sell
17,841
-10,700
-37% -$525K 0.01% 262
2025
Q1 		$1.74M Buy
28,541
+2,629
+10% +$153K 0.02% 213
2024
Q4 		$1.47M Buy
25,912
+1,703
+7% +$95.2K 0.02% 215
2024
Q3 		$1.25M Buy
24,209
+1,243
+5% +$58.3K 0.01% 238
2024
Q2 		$954K Sell
22,966
-8,600
-27% -$385K 0.01% 276
2024
Q1 		$1.71M Buy
31,566
+12,266
+64% +$625K 0.02% 233
2023
Q4 		$990K Sell
19,300
-9,372
-33% -$492K 0.01% 274
2023
Q3 		$1.66M Buy
28,672
+16,684
+139% +$1.02M 0.02% 229
2023
Q2 		$767K Hold
11,988
– – 0.01% 345
2023
Q1 		$831K Buy
+11,988
New +$846K 0.01% 352
2020
Q3 		$985K Hold
16,344
– – 0.07% 189
2020
Q2 		$961K Buy
+16,344
New +$978K 0.09% 136
2020
Q1 		– Sell
-16,344
Closed -$1.05M – 177
2019
Q4 		$1.05M Hold
16,344
– – 0.16% 71
2019
Q3 		$829K Hold
16,344
– – 0.13% 79
2019
Q2 		$741K Sell
16,344
-1,800
-10% -$83.8K 0.12% 79
2019
Q1 		$866K Hold
18,144
– – 0.13% 79
2018
Q4 		$924K Hold
18,144
– – 0.14% 77
2018
Q3 		$1.13M Hold
18,144
– – 0.15% 74
2018
Q2 		$1.01M Buy
18,144
+2,400
+15% +$130K 0.12% 79
2018
Q1 		$996K Hold
15,744
– – 0.14% 74
2017
Q4 		$975K Sell
15,744
-700
-4% -$43.8K 0.13% 78
2017
Q3 		$1.07M Hold
16,444
– – 0.15% 75
2017
Q2 		$916K Buy
16,444
+1,600
+11% +$87.1K 0.07% 176
2017
Q1 		$791K Buy
+14,844
New +$814K 0.08% 119
2016
Q4 		– Sell
-11,644
Closed -$628K – 126
2016
Q3 		$628K Sell
11,644
-14,269
-55% -$917K 0.05% 187
2016
Q2 		$1.91M Sell
25,913
-1,000
-4% -$70.7K 0.19% 111
2016
Q1 		$1.72M Sell
26,913
-1,700
-6% -$107K 0.17% 109
2015
Q4 		$1.97M Buy
28,613
+500
+2% +$33K 0.22% 96
2015
Q3 		$1.66M Hold
28,113
– – 0.2% 98
2015
Q2 		$1.87M Sell
28,113
-3,300
-11% -$217K 0.21% 95
2015
Q1 		$2.03M Sell
31,413
-99,014
-76% -$6.2M 0.23% 94
2014
Q4 		$7.7M Sell
130,427
-30,410
-19% -$1.71M 0.91% 28
2014
Q3 		$8.23M Sell
160,837
-14,676
-8% -$733K 0.89% 27
2014
Q2 		$8.51M Buy
175,513
+148,500
+550% +$7.32M 0.75% 25
2014
Q1 		$1.4M Sell
27,013
-2,000
-7% -$106K 0.21% 106
2013
Q4 		$1.54M Hold
29,013
– – 0.2% 101
2013
Q3 		$1.34M Sell
29,013
-2,000
-6% -$87.8K 0.19% 111
2013
Q2 		$1.39M Buy
+31,013
New +$1.35M 0.21% 102

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Perpetual Ltd's BMY Position: Q2 2026 in Review

Perpetual Ltd reduced its Bristol-Myers Squibb (BMY) stake by 27% in Q2 2026, selling an estimated $986K and leaving 45,645 shares worth $2.63M. The position accounts for 0.04% of the portfolio, ranked #156.

Perpetual Ltd first reported a position in BMY in Q2 2013 and has held it in 42 quarters since. The position peaked at $8.51M in Q2 2014. 829 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Perpetual Ltd held 45,645 shares of Bristol-Myers Squibb worth $2.63M as of Q2 2026.
  • Perpetual Ltd sold 17,170 Bristol-Myers Squibb shares in Q2 2026, an estimated $986K.
  • Bristol-Myers Squibb made up 0.04% of Perpetual Ltd's portfolio in Q2 2026, its #156 holding.
  • Perpetual Ltd first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 42 quarters since.
  • Perpetual Ltd's Bristol-Myers Squibb position peaked at $8.51M in Q2 2014.
  • 829 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.